Adrian L Harris is the Cancer Research UK Professor of Medical Oncology at the University of Oxford and directs the Cancer Research UK Molecular Oncology Laboratories at the Weatherall Institute of Molecular Medicine (WIMM). He is a Consultant Medical Oncologist and a Professorial Fellow of St Hugh’s College Oxford. He is Editor-in-Chief of the British Journal of Cancer and on the Editorial Board of Cancer Cell. He is a Senior Investigator in the National Institute of Health Research and a Fellow of the Academy of Medical Sciences.
He is a ‘Highly Cited Researchers (h>100) according to their Google Scholar Citations, 2019 ‘ ranking among the top 1% most cited for their subject field 2009 and 2019., h score 191. He is also listed in Boyack KW, et al. A list of highly influential biomedical researchers, 1996-2011. Eur J Clin Invest. 2013 43:1339-65. These are Top 400 world-wide cited investigators in all biomedical fields. He has published over 500 papers and there are over 105,000 citations to them.
His major laboratory interests involve the role of hypoxia in breast tumour biology. This includes tumour angiogenesis, endocrine therapy resistance, the metabolic response to hypoxia, noncoding RNAs induced by hypoxia and hypoxia-induced cell death, interferon signalling. He has conducted many predictive and prognostic studies in breast cancer, and early exploratory phase trials in new drug development, molecular pathology and biomarkers to develop new agents with pharmacodynamic monitoring for proof of target engagement.